<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Edinburgh Research and Innovation</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/17D4BE52-C9D2-4E01-A6C6-4726D4A4AA83"><gtr:id>17D4BE52-C9D2-4E01-A6C6-4726D4A4AA83</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Rogers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2BEF7304-7331-4E36-B717-541FF9ECBC0A"><gtr:id>2BEF7304-7331-4E36-B717-541FF9ECBC0A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>MacEwan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8DDA911C-CBC8-4BD1-8DE1-E7FC4D89C88C"><gtr:id>8DDA911C-CBC8-4BD1-8DE1-E7FC4D89C88C</gtr:id><gtr:firstName>Alasdair</gtr:firstName><gtr:surname>MacKenzie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1E9ED8CE-0D66-4BCB-8CC9-91B5A698F8BA"><gtr:id>1E9ED8CE-0D66-4BCB-8CC9-91B5A698F8BA</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:surname>Ralston</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300413"><gtr:id>EEADEA56-6F96-411D-81A3-D33495FEBF58</gtr:id><gtr:title>Role of SQSTM1 in Paget's Disease of Bone and the regulation of normal bone turnover</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300413</gtr:grantReference><gtr:abstractText>The principal applicant is advisor to the National Association for Relief of Pagets disease (a patient self-help group) and has lectured widely to medical and lay audiences on Pagets disease and related disorders. The bone research group web site also contains information relevant to public understanding of the disease.</gtr:abstractText><gtr:technicalSummary>Paget?s disease of bone (PDB) is a common disorder, which affects about 3% of individuals over the age of 55 years in the UK. The disease is characterised by focal abnormalities of bone turnover, which disrupt normal bone architecture, causing bone pain, bone deformity, deafness, osteoarthritis and pathological fractures. Genetic factors are important in PDB and we recently identified mutations in the sequestosome 1 (SQSTM1) gene as a common cause of both familial and sporadic PDB. The aims of this programme are to define the molecular mechanism by which SQSTM1 gene mutations affect bone cell function and to develop an animal model for PDB, by knock-in of representative mutations to transgenic mice. This will allow us to explore the factors that determine when, where and why bone lesions develop in patients with SQSTM1 mutations. The research programme is important, not only for understanding the pathogenesis of PDB, but also for understanding the basic mechanisms by which the SQSTM1 gene product regulates normal bone turnover and links bone resorption to bone formation.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>205648</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences</gtr:department><gtr:description>SQSTM1 mutations and disease severity in PDB</gtr:description><gtr:id>7C7CA003-71BE-4F1B-A954-90E8C83BF187</gtr:id><gtr:impact>This research will help to clarify if the type of mutation is related to clinical severity of Paget's disease</gtr:impact><gtr:outcomeId>21F5312B74F-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator is Dr Rob Layfield who has devised methods to assess the effect of different SQSTM1 mutations on binding affinity for Ubiquitin. We are using this data to determine if the clinical severity of PDB is related to the affect of different mutations on ubiquitin binding affinity</gtr:partnerContribution><gtr:piContribution>We are supplying the clinical data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NARPD Members Day</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>77C6D504-FEF8-41AC-825D-9733B850B1D8</gtr:id><gtr:impact>I have presented the result of our ongoing research to the &amp;quot;members day&amp;quot; of the National Association for relief of Paget's disease (NARPD) a patient organisation

This has raised awareness of the important of genetic factors in Paget's and helped us enroll patients into the MRC-funded ZIPP study</gtr:impact><gtr:outcomeId>BF0499F1655</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:fundingRef>19799</gtr:fundingRef><gtr:id>4FCCDD86-96EF-4FFD-B861-1E242CD6D2BE</gtr:id><gtr:outcomeId>Caf5PeqjTm6</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>464415</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Models of Disease</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0800933</gtr:fundingRef><gtr:id>D877F8E2-F85F-4D2E-934D-DED1CC2F35A1</gtr:id><gtr:outcomeId>24095D703480</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council Charity, John Wheale Bequest</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>55A4591C-46B5-4CAC-A573-8018CAD8EC7B</gtr:id><gtr:outcomeId>6480B7E83CE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is a mouse model of SQSTM1 mediated Paget's which recapitulates many features of the disease</gtr:description><gtr:id>6A4AB7E6-C124-46E9-8B95-2AD0504DDEE9</gtr:id><gtr:impact>We have presented data on the phenotype of this model at several meetings including ASBMR where the presenter won a &amp;quot;young investigator&amp;quot; award. A paper has been published describing the phenotype of the mouse.</gtr:impact><gtr:outcomeId>5263AA983FB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>SQSTM1 P394L mutant mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8F8B341A-C6B3-4C7F-B34A-2C86170AC31C</gtr:id><gtr:title>Secular changes in Paget's disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain.</gtr:title><gtr:parentPublicationTitle>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3283eb0791b7a686869362f952aef4b8"><gtr:id>3283eb0791b7a686869362f952aef4b8</gtr:id><gtr:otherNames>Corral-Gudino L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0937-941X</gtr:issn><gtr:outcomeId>pm_13351_21_22395312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAF7EB36-5AF8-4BFE-AF81-F1C092AD71E6</gtr:id><gtr:title>Mutant p62/SQSTM1 UBA domains linked to Paget's disease of bone differ in their abilities to function as stabilization signals.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13970cf1ae1a500412dc19a6e16bab79"><gtr:id>13970cf1ae1a500412dc19a6e16bab79</gtr:id><gtr:otherNames>Heinen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_13351_21_20230821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D8C003B-0104-4786-BD2D-9CFD35CAC952</gtr:id><gtr:title>Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bd54cb4790776e4959982b8e578a6f"><gtr:id>c5bd54cb4790776e4959982b8e578a6f</gtr:id><gtr:otherNames>Albagha OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>pm_13351_21_23658060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8FCA111-4E9E-400B-96B5-F845CF107357</gtr:id><gtr:title>A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/349a6520453abc0255e594b7cdcddd51"><gtr:id>349a6520453abc0255e594b7cdcddd51</gtr:id><gtr:otherNames>Daroszewska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13351_21_21515589</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300413</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>